Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation

Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 135, Issue 2, February 2015, Pages 551-553.e3

Eleanor MRCPI, Tariq MSc, Maeve A. MRCPI, Niall PhD, FRCPath, Conleth MD, Desa MD, PhD, Alan D. MD,